Steen Anderson appointed CEO of ProBiotix Health

LONDON, UK: ProBiotix Health Plc has announced the appointment of Steen Andersen as Chief Executive Officer (CEO). Steen will join the Company after completing his notice period with his current employer. This appointment is part of a long-planned strategy to appoint an experienced industry business leader to the Company to drive sales and profitability, leaving…

OptiBiotix intends to list ProBiotix Health on the AQSE Growth Market

LONDON, UK: OptiBiotix Health plc (AIM: OPTI), a life sciences business, intends to seek admission of its wholly owned subsidiary, ProBiotix Health Limited , onto the AQSE Growth Market with an associated fund raise and distribution in specie. Key points • Proposed £2.5m fundraise by ProBiotix Health by way of placing and subscription. • EIS/VCT qualifying. • A distribution in specie of ProBiotix Health…